IGM Biosciences Inc (NAS:IGMS)
$ 7.24 -0.07 (-0.96%) Market Cap: 427.33 Mil Enterprise Value: 174.49 Mil PE Ratio: 0 PB Ratio: 2.65 GF Score: 34/100

IGM Biosciences Inc at Bank of America Global Healthcare Conference Transcript

May 09, 2023 / 10:40PM GMT
Release Date Price: $12.73 (+0.47%)
Gregory Allen Harrison
BofA Securities, Research Division - Analyst

Welcome to day 1 of the Bank of America Healthcare Conference. I'm Greg Harrison, one of the biotech analysts here at BofA. And today, we have IGM Biosciences with us. And from IGM, we have Fred Schwarzer, Chief Executive Officer. Thanks for joining us, Fred.

Fred M. Schwarzer
IGM Biosciences, Inc. - CEO, President & Director

Thanks for having us. I appreciate it.

Gregory Allen Harrison
BofA Securities, Research Division - Analyst

Maybe you'd like to start off with a couple of opening remarks, and then we can jump into Q&A.

Fred M. Schwarzer
IGM Biosciences, Inc. - CEO, President & Director

Sure. I guess I probably would focus on the 2 most important programs in our pipeline that we at least -- the programs are the furthest along right now, and the first would be our Death Receptor 5 program, where we showed some really interesting data we thought at -- in January at a competitor's

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot